Tenderwize
Zurück zur Suche

CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD

Department of Contracts·Floriana, Malta·EUR 5.6M·Expired · Jul 15, 2026·Open·Supplies
High valueStructured notice only
Originaltitel der Bekanntmachung

Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD

60/100

Opportunity Score

Needs reviewMedium complexity
SuppliesExpired
Warum diese Bewertung?

Chance

60 / 100

Komplexität

45 / 100

Risikofaktoren

Award criteria and selection criteria are not disclosed, making bid preparation speculative.

Framework contract may not guarantee any minimum purchase volume.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • EUR 5.6M estimated value
  • Supplies contract
  • 1 lot
  • Supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for Inflammatory Bowel Disease (IBD)
  • Framework contract; no quantities or minimum spend specified
Vollständige Zusammenfassung anzeigen

This is an open procedure framework contract for the supply of selective Janus Kinase 1 inhibitor tablets/prolonged release tablets/capsules for inflammatory bowel disease (IBD). The contract is for a single lot with an estimated total value of €5,608,254.60. The buyer is the Department of Contracts in Malta. The deadline for submission is 15 July 2026 at 07:30 (Malta time). Electronic submission is required in English. The notice does not disclose award or selection criteria; only an ESPD (European Single Procurement Document) is referenced. No procurement documents were analyzed beyond the notice.

Risiken

Award criteria and selection criteria are not disclosed, making bid preparation speculative.

Framework contract may not guarantee any minimum purchase volume.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must supply pharmaceutical products classified under CPV 33693100

Administrative

  • Electronic submission via eTenders Malta portal
  • Tender must be submitted in English

Anforderungen können unvollständig sein.

Auftraggeber

Ort

Floriana, MLT

Auftraggeberprofil

Profil öffnen

Kennung

MT25645419

Tätigkeit

General public services

Lose (1)

LOT-0001

CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD

Supply of selective JAK1 inhibitor tablets/prolonged release tablets/capsules for IBD.

SuppliesEU fundedElectronic submission

EUR 5.6M

Geschätzter Wert

Ort

MT001, Malta

Kategorie

Toxins

Frist

Expired Jul 15, 2026

Vergabedetails

Veröffentlichungsdatum
10 Jun 2026
Sprachen
English

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
400302-2026

Dokumente (2)